Back
Sabre Vs. UiPath Industry Stock Comparison
Buy
54
SABR
Sabre
Last Price:
$3.86
Seasonality Move:
-9.68%
Sell
40
PATH
UiPath
Last Price:
$13.25
Seasonality Move:
-1.3%
Sell
40
UiPath (PATH)
is a Sell
Is UiPath a Buy, Sell or Hold?
-
PATH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SABR Stock Price Chart
SABR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 52.95 | Buy |
Chaikin Money Flow: | 1632985 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.7 - 3.92) | Buy |
Bollinger Bands (100): | (3.06 - 3.78) | Buy |
PATH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 44.21 | Sell |
Chaikin Money Flow: | 12505589 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.12 - 14.84) | Sell |
Bollinger Bands (100): | (11.82 - 13.74) | Buy |
SABR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.88 | Sell |
20-day SMA: | 3.83 | Buy |
50-day SMA: | 3.69 | Buy |
200-day SMA: | 3.09 | Buy |
8-day EMA: | 3.85 | Buy |
20-day EMA: | 3.82 | Buy |
50-day EMA: | 3.69 | Buy |
200-day EMA: | 3.44 | Buy |
PATH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.73 | Sell |
20-day SMA: | 14.26 | Sell |
50-day SMA: | 13.39 | Sell |
200-day SMA: | 15.01 | Sell |
8-day EMA: | 13.61 | Sell |
20-day EMA: | 13.86 | Sell |
50-day EMA: | 13.54 | Sell |
200-day EMA: | 14.68 | Sell |
Sabre Earnings Growth & SABR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and an increase next year of $0.35 per share.
UiPath Earnings Growth & PATH Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.10 per share, an increase this year of $0.41 per share, and a decrease next year of $0.00 per share.
Sabre Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
UiPath Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |